Latin America is a diverse region with more than 500 million people and approximately 8 million HCV infected individuals. The recent description of genetic polymorphisms associated to the interleukin 28B gene that predicts the response to treatment in these patients has impacted the clinical algo...
Enlace original:
https://repositorio.uc.cl/handle/11534/27438
Soza, Alejandro
,
López Lastra, Marcelo Andrés
,
[IL28B Polymorphisms Among Latin American HCV Patients]
,
IL28B Polymorphisms Among Latin American HCV Patients
